AFC
GMED icon

Ares Financial Consulting’s Globus Medical GMED Stock Holding History

Ares Financial Consulting’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05K Buy
+26
New +$2.21K ﹤0.01% 878

Other funds holding GMED

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Ares Financial Consulting's GMED Position: Q2 2026 in Review

Ares Financial Consulting opened a new position in Globus Medical (GMED) in Q2 2026: 26 shares worth $2.05K. The stake represents ﹤0.01% of the portfolio and ranks #878 among its holdings.

271 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Ares Financial Consulting held 26 shares of Globus Medical worth $2.05K as of Q2 2026.
  • Globus Medical was a new Ares Financial Consulting position in Q2 2026.
  • Globus Medical made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #878 holding.
  • 271 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.